welcome

This website uses cookies to ensure you get the best experience on our website.
Please scroll to the bottom of page to read the notice if you are coming from the European Union...

Wednesday, August 21, 2013

The Suppliment Industry Would Love To Get Their Hands On This


 Eat burgers all you want when ever you want. We have the perfect solution for you...



"A drug known as SR9009, which is currently under development at The Scripps Research Institute, increases the level of metabolic activity in skeletal muscles of mice. Treated mice become lean, develop larger muscles and can run much longer distances simply by taking SR9009, which mimics the effects of aerobic exercise. If similar effects can be obtained in people, the reversal of obesity, metabolic syndrome, and perhaps Type-II diabetes might be the very welcome result."

No comments:

Post a Comment